[1]刘 栋,胡 敏,张翠杰,等.五酯软胶囊联合他克莫司治疗乙肝相关性膜性肾病临床研究*[J].陕西中医,2020,(3):331-333,363.
　LIU Dong,HU Min,ZHANG Cuijie,et al.Clinical study on the treatment of hepatitis B associated-membranous nephropathy with Wuzhi soft capsule combined with tacrolimus[J].,2020,(3):331-333,363.
点击复制

五酯软胶囊联合他克莫司治疗乙肝相关性膜性肾病临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年3期
页码:
331-333,363
栏目:
临床研究
出版日期:
2020-03-05

文章信息/Info

Title:
Clinical study on the treatment of hepatitis B associated-membranous nephropathy with Wuzhi soft capsule combined with tacrolimus
文章编号:
DOI:10.3969/j.issn.10007369.2020.03.017
作者:
刘 栋; 胡 敏; 张翠杰; 李芳华; 翟亚玲
郑州大学第一附属医院肾内科(郑州 450002)
Author(s):
LIU Dong; HU Min; ZHANG Cuijie; et al.
Department of Nephrology,the First Affiliated Hospital of Zhengzhou University(Zhengzhou 450002)
关键词:
乙肝相关性膜性肾病;  他克莫司;  五酯软胶囊;  益肾化瘀;  益气补血
Keywords:
Hepatitis B associated-membranous nephropathy;  Tacrolimus;  Wuzhi soft capsule;  Yishen Huayu;  Yiqi Buxue
分类号:
R512.6
文献标志码:
A
摘要:
目的:探讨益肾化瘀中药联合他克莫司胶囊对乙肝相关性膜性肾病的治疗效果。方法:选取HBV-MN病患者共80例,随机分为两组,对照组采用常规他克莫司胶囊,观察组给予他克莫司胶囊联合五酯软胶囊。结果:观察组与对照组治疗后,24h尿蛋白分别为(0.99±2.94)g/L和(2.94±1.57)g/L,血肌酐分别为(82.44±3.17)mmol/L和(101.33±2.47)mmol/L; 白蛋白含量分别为(37.05±2.49)g/L和(31.47±5.27)g/L,五酯软胶囊加入后,降低了24 h尿蛋白、血肌酐,增加血液中白蛋白含量。降低肝病毒在体内的存活率。结论:益肾化瘀的五酯软胶囊联合他克莫司药物,对HBV-MN治疗有促进作用。
Abstract:
Objective:To investigate the effect of Yishen Huayu prescription combined with tacrolimus on the treatment of hepatitis B associated-membranous nephropathy.Methods:80 patients with hepatitis B virus associated- membranous nephropathy were randomly divided into two groups.The control group received conventional tacrolimus capsule and the observation group received tacrolimus capsule combined with Wuzhi soft capsule to treat HBV-MN were patients.Results:After treatment,the urine protein in the observation group and the control group were(0.99±2.94)g/L and(2.94±1.57)g/L at 24h,the blood creatinine was(82.44±3.17)mmol/L and(101.33±2.47)mmol/L,the albumin content were(37.05±2.49)g/L and(31.47±5.27)g/L,respectively.Reduces the survival rate of liver viruses in the body.Conclusion:Wuzhi soft capsule can significantly increase the effect of tacrolimus and promote the treatment of hepatitis B virus associated- membranous nephropathy.

参考文献/References:

[1] 张景凤,关 爽,刘树军,等.乙肝相关性肾炎临床及病理分析[J].中国实验诊断学,2018,22(3):495-497.
[2] 王春燕,郝金翠,王晓玲,等.抗病毒治疗在乙肝相关性肾炎患者激素、免疫抑制剂治疗过程中应用[J].临床军医杂志,2018,46(1):65-67.
[3] 韩 璐.他克莫司缓释剂型与普通剂型治疗膜性肾病的临床观察[D].长春:吉林大学,2018.
[4] Staatz CE,Tett SE.Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation[J].Clinical Pharmacokinetics,43(10):623-53.
[5] Staatz CE,Goodman LK,Tett SE.Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitorsPart I[J].Clinical Pharmacokinetics,49(3):141-75.
[6] 朱 平,谢 莉,杨 林.乙肝病毒感染相关肾小球肾炎治疗新进展[J].湖北医药学院学报,2014,33(2):189-193.
[7] 刘建木.五酯软胶囊防治药物性肝损害临床观察[J].中国实用医药,2009,4(35):118-119.
[8] 吴 静.他克莫司联合五酯软胶囊治疗膜性肾病的临床观察[D].郑州:河南中医学院,2015.
[9] 范晓光.五酯软胶囊对MN患者FK506浓度影响的临床观察[A].中国中西医结合学会肾脏疾病专业委员会.中国中西医结合学会肾脏疾病专业委员会2018年学术年会论文摘要汇编[C].中国中西医结合学会肾脏疾病专业委员会:中国中西医结合学会,2018:1.
[10] 成立丽,唐艳玲,阚淑娟.抗病毒联合保肾治疗乙肝病毒相关肾炎临床分析[J].温州医学院学报,2009,39(5):499-500.
[11] 袁 琦.抗乙肝病毒治疗与抗乙肝病毒联合应用免疫抑制剂治疗乙肝相关肾炎的临床观察[D].长春:吉林大学,2013.
[12] 张冬云.中西医结合治疗乙型肝炎病毒相关肾炎临床研究[J].中国医药导刊,2009,11(3):377.
[13] 高志芳,范肖芳,侯晓涛,等.不同乙肝相关性肾病的病理特征及病毒抗原沉积特点比较[J].检验医学与临床,2019,16(13):1876-1879.
[14] 郑博文.乙型肝炎病毒相关性膜性肾病的临床和病理分析[D].郑州:郑州大学,2019.
[15] 牛 丹.乙肝病毒血清学阳性肾组织中HBX蛋白表达及HBV-DNA检测的意义及应用[D].太原:山西医科大学,2019.
[16] Plosker GL,Foster RH.Tacrolimusa further update of its pharmacology and therapeutic use in the management of organ transplantation[J].Drugs,2000,59(2):323-389.
[17] Mendoza SA,Reznik VM,Griswold WR,et al.Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents[J].Pediatr Nephrol,1990,4(4):303-307.
[18] 冯 威.小剂量激素联合他克莫司治疗特发性膜性肾病的临床分析[J].中国冶金工业医学杂志,2019,36(4):457-458.
[19] 王沁园,王 静.他克莫司在肾病综合征治疗中的作用研究[J].中国医学前沿杂志:电子版,2019,11(6):113-116.
[20] 于 洋,杨玉清,田继华.他克莫司对系膜增生性肾小球肾炎作用机制的研究[J].中国药物与临床,2019,19(14):2354-2356.
[21] 胡正芳,李除夕,柳 燕,等.南五味子软胶囊的一般药理作用研究[J].中国实验方剂学杂志,2014,20(5):184-187.
[22] 孙永嘉,严铭铭,万志强,等.五味子软胶囊镇静安神的药效学研究[J].时珍国医国药,2012,23(6):1432-1433.
[23] 陈素枝,檀金川,陈文军.檀金川教授从“肝肾同源”辨治乙型肝炎病毒相关性肾炎经验[J].中国中西医结合肾病杂志,2015,16(8):728-729.
[24] 张晓凤,程小红,田 耘,等.特发性膜性肾病中医证候分布与临床病理分期的相关性研究[J].陕西中医,2017,38(8):1051-1053.

备注/Memo

备注/Memo:
*国家自然科学基金青年科学基金资助项目(81600555)
更新日期/Last Update: 2020-04-07